| scholarly article | Q13442814 |
| P2093 | author name string | Kinney TR | |
| Mitchell BS | |||
| Kurtzberg J | |||
| Hershfield MS | |||
| Kredich NM | |||
| Koller CA | |||
| Falletta JM | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| lymphoblastic leukemia | Q18553852 | ||
| T-cell acute lymphoblastic leukemia | Q55949881 | ||
| P304 | page(s) | 3451-3458 | |
| P577 | publication date | 1983-07-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine | |
| P478 | volume | 43 |
| Q41521392 | Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency |
| Q36246013 | Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin |
| Q28360364 | Covalent labelling of ligand binding sites of human placental S-adenosylhomocysteine hydrolase with 8-azido derivatives of adenosine and cyclic AMP |
| Q39246291 | Enzymes of purine metabolism in lymphoid neoplasms, clinical relevance for treatment with enzyme inhibitors |
| Q40394290 | Evolution of the Arabinosides and the Pharmacology of Fludarabine |
| Q35212333 | Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. |
| Q55038410 | Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas. |
| Q42866186 | S-Adenosylhomocysteine hydrolase from human placenta. Affinity purification and characterization |
Search more.